(Q54610701)

1 June 2018

title

Trastuzumab plus chemotherapy in gastric cancer overexpressing HER-2 and EGFR: a case report. (English)

1 reference

1 June 2018

1 reference

1 reference

3

Elke Jäger

1 reference

1 June 2018

author name string

Salah-Eddin Al-Batran

series ordinal

1

1 reference

1 June 2018

Margarete Ruppert

series ordinal

2

1 reference

1 June 2018

publication date

17 January 2011

1 reference

1 June 2018

published in

Onkologie

1 reference

1 June 2018

volume

34

1 reference

1 June 2018

issue

1-2

1 reference

1 June 2018

page(s)

42-45

1 reference

1 June 2018

Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer

cites work

1 reference

Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients

21 January 2018

1 reference

EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number

21 January 2018

1 reference

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

21 January 2018

1 reference

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

21 January 2018

1 reference

Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer

21 January 2018

1 reference

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines

21 January 2018

1 reference

The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.

21 January 2018

1 reference

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000323345

1 reference

1 June 2018

PubMed ID

21346384

1 reference

1 June 2018